Crestchem Ltd vs Eiko Lifesciences Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Mar 18, 2026

Key Highlights

The Latest Trading Price of Crestchem Ltd is ₹ 86.11 as of 18 Mar 11:41 . The P/E Ratio of Crestchem Ltd is 0 as of March 2025 .The P/E Ratio of Eiko Lifesciences Ltd is 31.1 as of March 2025 . The Market Cap of Crestchem Ltd is ₹ 0 crore as of March 2025 .The Market Cap of Eiko Lifesciences Ltd is ₹ 65.15 crore as of March 2025 . The revenue of Crestchem Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of Eiko Lifesciences Ltd for the Dec '25 is ₹ 12.33 crore as compare to the Sep '25 revenue of ₹ 11.97 crore. This represent the growth of 3.01% The ebitda of Crestchem Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of Eiko Lifesciences Ltd for the Dec '25 is ₹ 2.22 crore as compare to the Sep '25 ebitda of ₹ 2.07 crore. This represent the growth of 7.25% The net profit of Crestchem Ltd changed from ₹ 0 crore to ₹ 0 crore over 7 quarters. This represents a CAGR of 0.0% The net profit of Eiko Lifesciences Ltd changed from ₹ 0.35 crore to ₹ 1.43 crore over 7 quarters. This represents a CAGR of 123.51% The Dividend Payout of Crestchem Ltd changed from 6.98 % on March 2024 to 10.99 % on March 2025 . This represents a CAGR of 25.48% over 2 yearsThe Dividend Payout of Eiko Lifesciences Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About Crestchem Ltd

Crestchem Limited was incorporated in April, 1991.
The Company is engaged in the field of processing / manufacturing/trading and marketing, of specialty chemical ingredients, the Companies products Caprylic / Capric Triglycerides in oil form and powder form and its down steam products also finds uses in Industrial fields and such other uses. The Company has developed two new products namely Capric / Caprylic Triglycerides and Lactose Free products, by indigenous technology efforts in the nutritional chemical field.

About Eiko Lifesciences Ltd

Eiko Lifesciences Limited was originally incorporated on January 07, 1977, under the name Narendra Investments (Delhi) Limited.
Later, the Company changed its name from Narendra Investments (Delhi) Limited to Eiko LifeSciences Limited effective from June 24, 2021.
Earlier, the Company engaged in sale and purchase of shares and securities.
At present, the Company is a leading manufacturer, supplier and exporter of Speciality Chemicals and Pharma Intermediates in India and globally. The Company commenced new business activity primarily in manufacturing of speciality and fine chemicals in October, 2020 from manufacturing facility located at Badlapur, Maharashtra and has since scaled its operations, grown brand and customer base to become the one of the fastest growing speciality chemicals companies in India.

FAQs for the comparison of Crestchem Ltd and Eiko Lifesciences Ltd

Which company has a larger market capitalization, Crestchem Ltd or Eiko Lifesciences Ltd?

Market cap of Crestchem Ltd is 26 Cr while Market cap of Eiko Lifesciences Ltd is 76 Cr

What are the key factors driving the stock performance of Crestchem Ltd and Eiko Lifesciences Ltd?

The stock performance of Crestchem Ltd and Eiko Lifesciences Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Crestchem Ltd and Eiko Lifesciences Ltd?

As of March 18, 2026, the Crestchem Ltd stock price is INR ₹86.99. On the other hand, Eiko Lifesciences Ltd stock price is INR ₹53.5.

How do dividend payouts of Crestchem Ltd and Eiko Lifesciences Ltd compare?

To compare the dividend payouts of Crestchem Ltd and Eiko Lifesciences Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.